a decreased energy intake relative to energy expenditure contribute to weight loss in Background -Weight loss is a frequently occurring problem in patients with lung patients with lung cancer. 4 The central localisation of the tumour and enhanced systemic cancer due to an increased resting energy expenditure (REE) and a decreased energy concentrations of inflammatory mediators are contributing factors to the increased REE. intake. The aim of the present study was to compare the metabolic and inflammatory Lung cancer can be subdivided into two groups according to its histology: small cell characteristics of patients with small cell lung carcinoma (SCLC) and non-small lung carcinoma (SCLC) and non-small cell lung carcinoma (NSCLC). Hypermetabolism cell lung carcinoma (NSCLC). The metabolic parameters of the lung cancer popu-occurs in both groups [5][6][7][8] and may be caused either by a direct effect of the tumour or as lation were compared with those of a healthy control group.
than one year, a body mass index (BMI) of   Thyroid stimulating hormone was assessed <30 kg/m 2 , a normal body temperature, and no evidence of physical or mental disease as with an immunoradiometric assay and cortisol was determined by a radioimmunoassay. assessed by physical examination. The study was approved by the medical ethical committee Plasma creatinine levels were used as a renal function parameter and were detected by the of the University Hospital of Maastricht. Informed consent was obtained from all patients modified Jassé reaction (Dimension, Dupont, France) . 19 and controls.
   ()     Forced expiratory volume in one second  REE was measured by indirect calorimetry (FEV 1 ) and inspiratory vital capacity (IVC) were measured with a wet spirometer (Pulusing a ventilated hood system (Oxycon , Mijnhardt, Bunnik, The Netherlands) as de-monet III; Gould Godart, Bilthoven, The Netherlands). The highest value of at least three scribed previously.
12 Measurements in patients were made at the metabolic ward over a 20 technically acceptable spirometric manoeuvres was used and the values were expressed as minute period between 07.00 hours and 09.00 hours under quiet conditions after an overnight percentages of the reference values. 20 fast in the hospital while at complete rest. Measurements in control subjects were performed similarly but on an outpatient basis.    Statistical analyses were performed using the Variations due to limited physical activities do not significantly influence the measurement Student's t test when appropriate, adjusted for multiple testing according to the method of of REE.
16 Body composition was assessed by bioelectrical impedance analysis as described Bonferroni. The Mann-Whitney U test was used for non-parametric data. Since impaired previously.
12
Weight loss was calculated as the difference renal clearance leads to increased concentrations of sTNF receptor, 21 the plasma between the reported stable weight before the illness (six months prior to investigation) and concentrations of sTNF-R55 and sTNF-R75
were analysed together with serum creatinine the actual weight. The control group had been weight stable for more than one year before levels. An analysis of covariance was therefore performed using plasma creatinine levels as a measurement. REE was expressed in absolute terms (REE) and adjusted for FFM according covariable with sTNF-R55 and sTNF-R75 as factors in the statistical model. Frequency data to the method of Ravussin and Bogardus. 17 The adjusted REE was calculated as the group were compared using the 2 test. Correlations were determined using the Pearson correlation mean REE plus measured REE minus predicted REE. The group REE is the mean ab-coefficient. Results are presented as mean (SD) . p values of <0.05 were considered statsolute REE (n=99), the measured REE is the resting metabolic rate in each subject, and istically significant. The statistical calculations were performed using the SPSS/PC+ 4.0 packthe predicted REE is the calculated energy expenditure obtained by using the individual age. 22 FFM in the linear regression equation of REE on FFM generated in the control group. Measured REE was also compared with predicted Results   REE using the Harris-Benedict equations 18 in order to allow comparison between this study Each group consisted of 24 men and nine women (table 1) . No differences were found and previous studies on REE in cancer patients. Subjects with a measured REE above 110% of in body weight or BMI among the three groups.
Ten patients with SCLC and 11 with NSCLC that predicted by the Harris-Benedict formula were arbitrarily considered hypermetabolic.
presented with more than 10% weight loss from their pre-illness weight. No significant differences in lung function parameters were found between the two groups of cancer     Blood was obtained by venepuncture before patients. Cortisol concentrations were significantly enhanced in patients with SCLC breakfast. Plasma was separated by centrifugation and stored at −70°C until analysis. compared with those with NSCLC (table 1) , although the mean concentration of cortisol Inflammatory mediators were measured using sandwich ELISA 12 and CRP was measured by was within the normal range (200-700 nmol/ l). turbidimetry. The detection limit of the assay was 5 g/ml. We were not able to measure inflammatory mediators in plasma of the control group, but in a previous study control    REE adjusted for FFM was significantly higher samples were obtained from 26 healthy elderly individuals. 12 The mean (SD) values of the in patients with lung cancer than in healthy controls (mean difference 214 kcal/day, 95% inflammatory mediators in plasma of healthy controls were as follows: sTNF-R55 1.0 CI 133 to 295; table 2). When the lung cancer population was divided according to tumour (0.3) ng/ml; sTNF-R75 1.1 (0.4) ng/ml; LBP 8.6 (3.1) g/ml, CRP <5 g/ml and TNF-was type REE adjusted for FFM was significantly higher in those with SCLC than in those with not detectable.
group (14) 105 (9) with lung cancer. sTNF-R55 (ng/ml) * 1.6 (0.9) 1.2 (0.7) 0.10 but they did not investigate possible reasons cancer, the expected weight loss over a six month period was calculated. A recently developed computer simulation model was used 23 NSCLC (mean difference 136 kcal/day, 95% CI 36 to 236). to calculate the expected weight change in a man aged 65 years of height 170 cm and weight FFM accounted for 69% (p<0.001) and FM for 7% (p<0.01) of the interindividual variation 65 kg with REE amounting to 113% of predicted. It was found that an increase in REE in REE in the healthy control group. In the NSCLC population FFM accounted for 48% of this amount would result in a weight loss of 7% which corresponds well with the results of (p<0.001) and FM for 3% (p>0.05) of the interindividual variation in REE. However, in this study.
 
In order to explain the differences in REE, the SCLC population the prediction of REE by body composition showed a different pattern factors contributing to REE were investigated.
Firstly, the influence of body composition on with FFM accounting for only 25% (p=0.01) of the interindividual variation in REE while REE was analysed. FFM accounted for 69% and 48% of the interindividual variation in FM accounted for 28% (p<0.001).
REE in controls and patients with NSCLC, respectively, while FFM accounted for only 25% of the variation in REE in patients with     To investigate the influence of tumour stage in SCLC. However, FM accounted for 28% of the variation in REE in patients with SCLC SCLC the patients were divided into those with limited disease (n=10) and those with and was a significant covariate in the significant difference in REE observed between patients extensive disease (n=23) (data not shown). No differences could be detected in metabolic with NSCLC and those with SCLC. These findings could indicate changes in carbohydrate parameters between the two populations. 
